This issue brings together two studies about how Parkinson’s may change over time and what a Parkinson’s-linked gene does inside cells. One studied ordinary clinical information and future decline; the other was an early cell study of LRRK2 and iron handling.
Routine clinical information outperformed brain MRI in estimating rapid change
🔍 How this came about
Researchers at the University of Miami built a machine-learning model using routine clinical information and brain MRI to estimate the chance of rapid cognitive or motor decline three to five years later. They defined rapid cognitive decline as a drop of at least five points on the Montreal Cognitive Assessment, and motor decline as a 10-point or greater rise on the MDS-UPDRS motor score.
They trained the model with data from 1,602 participants in the Parkinson’s Progression Markers Initiative and checked it in a separate group of 541 people. Age, symptom scores and disease duration — information already gathered in ordinary care — were more useful for separating risk than structural changes on MRI. Adding the direction of change during the first year improved performance by about 5%.
✅ If you live with Parkinson’s
This does not mean MRI is unnecessary. It means that the information already measured in a neurology visit can be highly informative. The model is not yet a routine test that can settle one person’s future or automatically choose treatment.
🙋 If you are a care partner
Before the next visit, note changes in walking, getting up, medication response, memory or attention, with dates. The most useful first step is to bring a clear record of real changes to the appointment, not to search for a new test on your own.
An LRRK2The leucine-rich repeat kinase 2 gene. Variants are associated with some forms of Parkinson's disease.Learn more variant disrupted iron handling in overloaded cells
🔍 How this came about
In a Journal of Cell Science study, researchers examined what happened when cells carrying the Parkinson’s-linked LRRK2 G2019S variant were exposed to too much iron. LRRK2 is involved in moving materials inside cells, so the team looked at iron-storage proteins and the process that clears them.
When iron was overloaded, the variant cells almost completely stopped breaking down NCOA4, an adapter involved in handling stored iron. Iron-related proteins became unbalanced, oxidative stress increased, and ferroptosis — iron-dependent cell death — became more common. Some changes were reduced by LRRK2 inhibitors, pointing to a link between trafficking and iron regulation.
✅ If you live with Parkinson’s
This is not a blood test or brain scan that can be used today. It is cell-model research showing one possible connection between LRRK2 and iron regulation. It does not mean you should start or stop an iron supplement, or change treatment.
🙋 If you are a care partner
Research findings should not be turned into a home diagnostic method. If an LRRK2 result or an iron level is a concern, ask the care team what the test means and why it was ordered. A treatment being studied is at a different stage from a treatment available in ordinary care.
What you can do now
Together, these studies show why Parkinson’s cannot be reduced to one number or one cause. For now, write down when changes in movement, thinking or medication response appear and bring that record to the next appointment.
This article is ParkinON’s plain-language summary of recently published research and news. It is not a substitute for medical diagnosis or treatment, and does not reflect approval or availability status in any specific country. Please talk to your care team about any questions regarding new treatments.